G9133 Onc diagnosis prostate clinical met
Also known as: clinical metastatic prostate cancer, prostate cancer with mets
Oncology diagnosis for prostate cancer with clinical evidence of metastatic disease.
In Plain Language
prostate cancer that has spread
Clinical Context
Documentation of prostate cancer patients with clinical evidence of metastatic disease, typically managed with androgen deprivation therapy.
RVU Information
CPT G9133 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9133?
CPT G9133 (Onc diagnosis prostate clinical met) is a G Codes code. Oncology diagnosis for prostate cancer with clinical evidence of metastatic disease.
Who uses CPT code G9133?
CPT G9133 is used by Medical Oncology, Urology, Surgical Oncology. Documentation of prostate cancer patients with clinical evidence of metastatic disease, typically managed with androgen deprivation therapy.
When is CPT G9133 used?
Documentation of prostate cancer patients with clinical evidence of metastatic disease, typically managed with androgen deprivation therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.